Wei Mao

Dr. Wei Mao

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
WMWei Mao
Wei Mao
GXGaofeng Xiong
Gaofeng Xiong
YWYuanyuan Wu
Yuanyuan Wu
CWChi Wang
Chi Wang
DSDaret St.Clair
Daret St.Clair
RXRen Xu
Ren Xu
Breast cancer development is associated with macrophage infiltration and differentiation in the tumor microenvironment. Our previous study highlights the crucial function of reactive oxygen species (ROS) in enhancing macrophage infiltration during the disruption of mammary tissue polarity. However, the regulation of ROS and ROS-associated macrophage infiltration in breast cancer has not been fully determined. Previous studies identified retinoid orphan nuclear receptor alpha (RORα) as a potential tumor suppressor in human breast cancer. In the present study, we showed that retinoid orphan nuclear receptor alpha (RORα) significantly decreased ROS levels and inhibited ROS-mediated cytokine expression in breast cancer cells. RORα expression in mammary epithelial cells inhibited macrophage infiltration by repressing ROS generation in the co-culture assay. Using gene co-expression and chromatin immunoprecipitation (ChIP) analyses, we identified complex I subunits NDUFS6 and NDUFA11 as RORα targets that mediated its function in suppressing superoxide generation in mitochondria. Notably, the expression of RORα in 4T1 cells significantly inhibited cancer metastasis, reduced macrophage accumulation, and enhanced M1-like macrophage differentiation in tumor tissue. In addition, reduced RORα expression in breast cancer tissue was associated with an increased incidence of cancer metastasis. These results provide additional insights into cancer-associated inflammation, and identify RORα as a potential target to suppress ROS-induced mammary tumor progression.

15 February 2025 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
QJQingyu Jiang
Qingyu Jiang
ZCZhiheng Chen
Zhiheng Chen
JJJin Jiang
Jin Jiang
QCQianping Chen
Qianping Chen
HLHuiyin Lan
Huiyin Lan
WMWei Mao
Wei Mao

13 November 2024 in Translational Oncology
Verified
Journal Article
Open access
ZDZhihao Dai
Zhihao Dai
JJJin Jiang
Jin Jiang
QCQianping Chen
Qianping Chen
MBMinghua Bai
Minghua Bai
QSQuanquan Sun
Quanquan Sun
JZJi Zhu
Ji Zhu
Gastric cancer (GC) is a common malignant tumor, and early diagnosis significantly improves patient survival rates. This study aimed to investigate the diagnostic value of ring finger protein 180 (RNF180) and secreted frizzled protein 2 (SFRP2) in GC. A total of 165 healthy individuals, 34 patients with precancerous gastric lesions, and 104 patients with confirmed GC were divided into training and validation sets; methylated RNF180 and SFRP2 were detected in circulating DNA from blood samples. Six models, including those based on logistic regression, Naive Bayes, K-nearest neighbor algorithm, glmnet, neural network, and random forest (RF) were built and validated. Area under the curve (AUC), sensitivity, specificity, positive predictive value, and negative predictive value were determined. In the training set, the RF model with RNF180 and SFRP2 (R + S) had an AUC of 0.839 (95 % CI: 0.727-0.951), sensitivity of 60.3 %, and specificity of 85.5 % for diagnosing GC. The RF model with R + S+ Tumor markers had an AUC of 0.849 (95 % CI: 0.717-0.981), sensitivity of 62.8 %, and specificity of 87.1 %. In the validation set, the RF model with R + S had an AUC of 0.844 (95 % CI: 0.774-0.923), sensitivity of 87.8 %, and specificity of 69.2 %. The RF model with R + S + Tumor markers had an AUC of 0.858 (95 % CI: 0.781-0.939), sensitivity of 85.4 %, and specificity of 76.9 %. Our results suggest that RNF180 and SFRP2 could serve as diagnostic biomarkers for GC when using the RF model.

8 January 2025 in Biology
Verified
Journal Article
Open access
PDF file
WMWei Mao
Wei Mao
XGXingnan Ge
Xingnan Ge
QCQianping Chen
Qianping Chen
JLJia-Da Li
Jia-Da Li
Almost all organisms, from the simplest bacteria to advanced mammals, have a near 24 h circadian rhythm. Circadian rhythms are highly conserved across different life forms and are regulated by circadian genes as well as by related transcription factors. Transcription factors are fundamental to circadian rhythms, influencing gene expression, behavior in plants and animals, and human diseases. This review examines the foundational research on transcriptional regulation of circadian rhythms, emphasizing histone modifications, chromatin remodeling, and Pol II pausing control. These studies have enhanced our understanding of transcriptional regulation within biological circadian rhythms and the importance of circadian biology in human health. Finally, we summarize the progress and challenges in these three areas of regulation to move the field forward.

29 August 2025 in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Verified
Journal Article
Closed access
LLLuyu Liao
Luyu Liao
YJYuzhao Jin
Yuzhao Jin
WMWei Mao
Wei Mao
JZJi Zhu
Ji Zhu
QCQianping Chen
Qianping Chen

11 August 2025 in Advanced Science
Verified
Journal Article
Open access
QCQianping Chen
Qianping Chen
YJYuzhao Jin
Yuzhao Jin
LLLuyu Liao
Luyu Liao
RSRong Shen
Rong Shen
XGXingnan Ge
Xingnan Ge
JZJi Zhu
Ji Zhu
More than 50% of patients with colorectal cancer (CRC) exhibit radioresistance, indicating the need for further research on the disease. Therefore, the aim of this study is to identify radioresistance genes and elucidate the underlying molecular mechanisms using patient‐derived organoids (PDOs). Transcriptome analyses are performed on radio‐resistant and ‐sensitive PDOs, CRC cells, and xenograft tissues to screen for radioresistant genes. Additionally, the genetic homology between PDOs and clinical tissues is verified using whole‐exome sequencing. Functional experiments are performed to validate the roles of the candidate genes using cellular, organoid, and animal models. Forkhead box P4 (FOXP4) is identified as a differentially expressed genes between the radio‐sensitive and ‐resistant groups that is linked to radioresistance. Further experiments show that FOXP4 promoted radioresistance by suppressing ferroptosis. Mechanistically, FOXP4 regulated GPX4 transcription by binding to the promoter region of GPX4 via the forkhead domain to inhibit the onset of ferroptosis. Doxorubicin (DOX) inhibited FOXP4 expression by promoting its ubiquitination and degradation, eventually increasing radiosensitivity. Notably, DOX combined with irradiation attenuated the compensatory increase in FOXP4 expression and increased radiotherapy efficacy. Conclusively, the combination therapy provides a new strategy for enhancing therapeutic efficacy in CRC.